A membrane-associated MHC-I inhibitory axis for cancer immune evasion
Chen X, Lu Q, Zhou H, Liu J, Nadorp B, Lasry A, Sun Z, Lai B, Rona G, Zhang J, Cammer M, Wang K, Al-Santli W, Ciantra Z, Guo Q, You J, Sengupta D, Boukhris A, Zhang H, Liu C, Cresswell P, Dahia P, Pagano M, Aifantis I, Wang J. A membrane-associated MHC-I inhibitory axis for cancer immune evasion. Cell 2023, 186: 3903-3920.e21. PMID: 37557169, PMCID: PMC10961051, DOI: 10.1016/j.cell.2023.07.016.Peer-Reviewed Original ResearchConceptsAcute myeloid leukemiaSolid cancersImmune evasionCancer immune evasionImmune checkpoint blockadeMultiple solid cancersMajor Histocompatibility Complex Class I Antigen PresentationPotential therapeutic targetCell-dependent mannerCell immunityCancer survivalMyeloid leukemiaAntigen presentationTherapeutic targetTransmembrane protein 127Tumor growthGene signatureCancer treatmentCancerPeptide-MHCMHCLeukemiaSushi domainTrimolecular complexE3 ubiquitin ligase WWP2A membrane-associated inhibitory axis of MHC-I presentation for cancer immune evasion
Lu Q, Chen X, Zhou H, Liu J, Nadorp B, Lasry A, Sun Z, Zhang J, Cammer M, Wang K, Ciantra Z, You J, Guo Q, Zhang H, Sengupta D, Boukhris A, Liu C, Cresswell P, Dahia P, Aifantis I, Wang J. A membrane-associated inhibitory axis of MHC-I presentation for cancer immune evasion. The Journal Of Immunology 2023, 210: 89.12-89.12. DOI: 10.4049/jimmunol.210.supp.89.12.Peer-Reviewed Original ResearchAcute myeloid leukemiaInhibitory axisSolid cancersImmune evasionT cell-dependent mannerCancer immune evasionImmune checkpoint blockadeT cell immunityNumber of tumorsMultiple solid cancersCell-dependent mannerApplicable therapeutic targetMDS FoundationCancer survivalMyeloid leukemiaTherapeutic targetTransmembrane protein 127Tumor growthGene signatureCancer treatmentMHCPeptide-MHCLeukemiaSushi domainCancer